DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
43 hedge funds and large institutions have $2.55M invested in DMK Pharmaceuticals Corporation Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Holders
43
Holding in Top 10
–
Calls
$169K
Puts
$4K
Top Buyers
| 1 | +$68.9K | |
| 2 | +$53.8K | |
| 3 | +$13.9K | |
| 4 |
VF
Virtu Financial
New York
|
+$9.57K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$3.69K |
Top Sellers
| 1 | -$50K | |
| 2 | -$43K | |
| 3 | -$19.7K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$14K |
| 5 |
HF
HRT Financial
New York
|
-$13K |